The Hidden Governance Cost of Fragmented AI in Medical Affairs
As global enterprises prepare to deploy over 150,000 AI agents by 2028, medical affairs teams face a mounting "tool-switching tax." Ome Ogbru, CEO of AINGENS, warns that using disconnected platforms for research, drafting, and citation creates fragmented scientific records that are increasingly difficult to govern, audit, and defend in regulated environments.

The drive to adopt specialized AI tools often leads to a disjointed workflow where literature searches, content drafting, and citation management occur in silos. According to Ogbru, this fragmentation imposes a significant cognitive load on employees who must master multiple interfaces, resulting in a loss of context each time they switch systems. Beyond the loss of efficiency, the lack of a unified digital trail complicates regulatory compliance, as teams struggle to reconstruct the provenance of scientific content.
Only 13% of organizations currently possess the necessary AI governance frameworks to manage such complexity. AINGENS, through its MACg platform, advocates for a consolidated workspace that embeds traceability directly into the development process. By integrating real-time PubMed access and evidence gathering into a single environment, firms can ensure that citations remain tethered to their source material. Ogbru emphasizes that governance must be established during the initial technology evaluation phase rather than as an afterthought, noting that an AI model alone cannot replace the robust infrastructure required to maintain scientific rigor.
Comments (0)
No comments yet. Be the first!